Cannabis Community, Investors React to DEA Decision To Reschedule
Cannabis advocates, executives and investors are celebrating the Drug Enforcement Administration’s reported decision this week to reclassify marijuana under federal drug laws, […]
Cannabis advocates, executives and investors are celebrating the Drug Enforcement Administration’s reported decision this week to reclassify marijuana under federal drug laws, […]
Trulieve Cannabis Corp.’s highly publicized $143 million federal income tax refund claims created a frenzy of hope that seems to offer the […]
Here’s how marijuana rescheduling could impact medical practitioners working in the cannabis space. Rescheduling could change how medical practitioners do business: Q&A […]
In the most unexpected development to hit the cannabis industry in years, the U.S. Department of Health and Human Services’ (HHS) Secretary […]
2022 brought more change and visibility to the cannabis industry than nearly any year before. Two of five legalization ballot measures passed, […]
The consumer-facing CBD industry operates in a regulatory gray zone even as it grows in prominence. Illegal to market as an unapproved […]
The overwhelming majority of Americans now live in a state where cannabis is legal at the state level for at least some […]